Novartis to acquire San Diego-based Regulus in deal worth up to $1.7B
Access to potential breakthrough treatment for kidney disease is a key part of the deal
Biotech
Illumina announces another round of layoffs in San Diego
The gene sequencing giant will lose 172 employees, on top of recently announced layoffs totaling...
Amid tariff turmoil, Swiss drugmaker commits to build $1.1B research hub in San Diego
Novartis plans to make San Diego the center of its West Coast research hub.
Pfizer sells San Diego campus for $255M
Separately, Pfizer also announced layoffs at the Science Center Drive facility.
China retaliates against San Diego’s Shield AI in tariff war
Shield AI, an artificial intelligence company that is one of San Diego's most valuable venture-backed...
Carlsbad’s Ionis strikes deal with Japanese pharma worth up to $940M
The companies will collaborate on the commercialization of Ionis' drug for a blood disease.
Dexcom receives FDA warning letter for 2 manufacturing sites
The local device maker received the letter last week regarding its San Diego and Arizona...
Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China's...
San Diego biotech gets FDA approval for EpiPen alternative for kids
The newly approved dosage of epinephrine nasal spray, Neffy, is geared toward children as young...
China hits Illumina with import ban. What does that mean for the San Diego gene sequencer?
China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating...
Illumina cuts workforce at San Diego headquarters
The local gene sequencing company cited cost savings to align with its future business strategy.
San Diego had its first biotech IPO of 2025. Are more on the way?
Aardvark Therapeutics became the first San Diego biotech to IPO this year.
UC San Diego ranks top 10 in world for universities driving innovation
The local university was ranked highly for its large volume of patents derived from research...
Mike Krenn, CEO of Connect, leaving nonprofit to lead new San Diego venture fund
After more than a decade at the networking outfit, Krenn will manage a new investment...
San Diego needs more money to enforce vacation rentals so it’s raising licensing fees
Hosts who rent out their entire homes for at least 90 days out of the...
San Diego’s Illumina placed on China’s ‘unreliable entity list’ following Trump tariffs
The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as...
San Diego’s vacant life science labs and offices continue to grow. Will the glut peak in 2025?
The vacancy rate continues to rise for San Diego County's life science labs and office...
Joe Panetta oversaw the growth of San Diego’s biotech scene for 25 years. Now, he’s ing the torch.
The voice of the biotech community takes on a new chapter after leading Biocom California...
Which San Diego startup landed the top deal of 2024? Hint: it’s not a biotech
San Diego County startups recorded $5.7 billion in venture capital dollars in 2024, but the...
Illumina partners with Nvidia on AI-powered genomic sequencing
The San Diego company said the collaboration with Nvidia is part of its growth strategy.
This San Diego biotech is moving its HQ to North Carolina
The local biotech company seeks growth and expansion opportunities in North Carolina.
Pharma giant Roche to buy San Diego biotech for up to $1.5B
Two San Diego biotechs struck big pharma deals each worth up to $1 billion, within...
San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offer
The San Diego biotech retracted its bid to buy German drugmaker Evotec a week after...
San Diego biotech Halozyme makes $2.1B bid for German drugmaker
San Diego-based Halozyme Therapeutics proposed an all cash acquisition of Evotec.
Even San Diego’s life science office buildings are sitting vacant. ‘We just oversubscribed on space.’
The region’s vacancy rate for life science lab and office space hit a record high...
Global medical technology firm shifts some of its San Diego manufacturing to Tijuana
CareFusion, a BD subsidiary, is conducting layoffs as well as moving some of its engineering...
San Diego’s life science startups continue to drive more than $1B in venture capital deals
Candid Therapeutics recorded San Diego's largest venture capital deal during the third quarter.
Danish pharma giant buys San Diego company’s epilepsy drug for $2.6B
La Jolla-based Longboard Pharmaceuticals has developed a drug for rare forms of epilepsy
San Diego’s Illumina unveils smaller, faster gene sequencer
San Diego-based Illumina announced its latest MiSeq i100 benchtop sequencers on Wednesday
Forget EpiPens. This San Diego biotech is offering the same medicine without needles
A San Diego company received FDA-approval to sell its epinephrine nasal spray called Neffy.
Robots take over Petco Park: 5 cool things we saw at Innovation Day
Startup founders, investors, and local universities flooded Petco Park for the annual celebration of innovation.
This nonprofit is investing in San Diego startups, but no one is getting rich
A new nonprofit is investing in San Diego startups as a way to raise money...
This pharmaceutical giant is building a new manufacturing site in Carlsbad
The new 10,000 square foot site will Novartis’ West Coast supply chain for cancer...
Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs
The San Diego company launched the first FDA-approved continuous glucose monitor that doesn't require a...
This San Diego medtech company is cutting 117 jobs
Local subsidiary of medtech giant Becton Dickinson & Co. is cutting jobs at two San...
Why is this biotech company selling its San Diego manufacturing facility?
It’s part of QuidelOrtho's cost-saving strategy, which included a 7 percent workforce reduction this year.
San Diego startups bring in more than $1B in venture capital funding
The amount of money raised by local companies is up 84.5% from the same period...
Pharmaceutical giant Novartis shutting down a San Diego site
Novartis is closing a San Diego site. The layoffs will be complete by mid-2025.
San Diego biotech news: Eli Lilly inks deal that could lead to $1B acquisition of this local company
San Diego's Radionetics inked deal with Eli Lilly to advance its oncology pipeline
Here’s why Eli Lilly, Pfizer and J&J are in San Diego looking for the next big drug
Will local startups give big pharma its next blockbuster drug? Eli Lilly and Pfizer are...
San Diego’s Dexcom cuts 500 jobs, moves manufacturing to Arizona
Dexcom is converting its San Diego manufacturing operations to research and development lab space.
San Diego biotech making melanoma skin patch files for Chapter 11 bankruptcy
While DermTech's melanoma test has gained insurance coverage with many groups, including Medicare, it has...
San Diego’s life science sector contributed $56.6B to the regional economy, despite tight financing and layoffs
Hiring in San Diego’s life science sector was down last year as a result of...
San Diego biotech news: Startup gets funding for drug that tackles overeating
Aardvark Therapeutics raised $85 million for its obesity-related drug and to a potential IPO...
San Diego COVID-19 test maker Cue Health files for bankruptcy following company closure
Cue Health filed for Chapter 7 bankruptcy shortly after the abrupt shutdown and layoff of...
San Diego gene-sequencer Illumina spins off blood testing startup Grail – for the second time
San Diego gene-sequencing giant Illumina said Monday that its board approved the spinoff of early...
San Diego’s life science industry has a new challenge: Too much space
San Diego's labs and life science offices hit record vacancy this year.
San Diego COVID-19 test maker Cue Health – once worth $2.3B – lays off entire company and shuts down
Cue Health, the once high-flying San Diego biotech supplying rapid COVID-19 test kits to the...
Pharmaceutical giant Takeda is shutting down its San Diego office
Pharmaceutical giant Takeda is shutting down its research and development hub in San Diego that...
San Diego’s Cue Health had the first FDA-approved home COVID-19 test. Now the agency says to throw them out.
The U.S. Food and Drug istration told consumers Monday to throw out any at-home COVID-19...
Illumina competitor Pacific Biosciences is closing its San Diego office, laying off workers
Genome sequencing company Pacific Biosciences, a competitor of Illumina, is shutting down its San Diego...
After fall in demand for COVID-19 tests, San Diego’s QuidelOrtho to lay off 500 workers
QuidelOrtho, a local diagnostic company that makes at-home COVID-19 test kits, has a new CEO...
San Diego biotech news: Local maker of mRNA used in COVID-19 vaccine opens new facility
San Diego-based TriLink BioTechnologies went from working with a few local biotechs in 2019 to...
Prebys Foundation awards $7 million in grants to 14 San Diego researchers
SAN DIEGO — Fourteen San Diego researchers will each receive $500,000 grants as part of a new...
This San Diego maker of COVID-19 tests is laying off half its workforce
Cue Health, a San Diego biotech that ascended during the pandemic through mega funding and...
This biotech startup got the biggest venture capital deal in San Diego so far this year
Funding deals for San Diego startups got off to a slow start this year, but...
Hiring is hot for government and health care jobs. These sectors boosted San Diego’s employment gains
Local government hiring fueled San Diego County's job growth last month and nudged the unemployment...
San Diego biotech company making melanoma test patch cuts 56% of its workforce
DermTech, the San Diego-based company that developed a noninvasive skin sticker to detect melanoma, is...
Illumina gets two new executives as the San Diego biotech revamps its C-suite
Illumina is getting a new chief financial officer, the latest major leadership change within the...
Thermo Fisher Scientific closing Carlsbad DNA manufacturing site less than 3 years after opening
Thermo Fisher Scientific is closing its Carlsbad DNA manufacturing site less than three years after...
Bristol Myers Squibb to lay off hundreds of workers following its $4.8B merger with this San Diego biotech
Following its $4.8 billion acquisition of local biotech Mirati Therapeutics, Bristol Myers Squibb is laying...
San Diego biotech news: Veteran life science execs raise $150M for cancer drug targeting hard-to-treat tumors
Veteran life science execs lead new company to big fundraising roundThe day that Athena Countouriotis,...
Johnson & Johnson, Pfizer, Eli Lilly and other big pharmas are backing this San Diego biotech with $175M
A San Diego biotech is working on therapies that could tackle life-altering conditions, like autoimmune...
Pfizer inks large deal for lab space at new Torrey View campus in San Diego
Pharmaceutical giant Pfizer has inked a deal to house its growing oncology business in a...
San Diego’s latest biotech, Contineum Therapeutics, files to go public
Contineum Therapeutics has filed to go public, becoming San Diego’s second biotech IPO of 2024.The...
This downtown San Diego life science building is now 50% leased with latest tenant
One San Diego building is filling up with biotechnology tenants as the push to make...
Startup Boundless Bio files to go public – San Diego’s first life science IPO of 2024
Local life science startup Boundless Bio filed Wednesday to go public — the first San...
San Diego’s Dexcom gets first FDA clearance for an over-the-counter wearable continuous glucose monitor
San Diego device maker Dexcom has received the first FDA clearance for a continuous glucose...
Volcanic explosions, lava lamps and robots entice families at San Diego’s annual science expo
SAN DIEGO — Periodic downpours Saturday were no match for ice cold volcanic eruptions, whimsical robots, and...
San Diego biotech firm QuidelOrtho fires longtime CEO
Local biotechnology firm QuidelOrtho ousted its longtime president and CEO, Douglas Bryant, on Wednesday. The...
DermTech, the San Diego biotech making a skin-cancer detecting patch, cuts 15% of workforce
DermTech, a San Diego biotechnology company that developed a noninvasive melanoma test, is reducing its...
Cue Health lays off more than 30 percent of its global workforce
Cue Health, a San Diego biotechnology company that grew rapidly from producing COVID-19 tests, is...
Illumina lays off 111 workers in San Diego
Illumina, the leader in DNA-sequencing technology, is laying off 111 people at its San Diego...
San Diego sees fewer startup deals in 2023 as investors write larger checks for select companies
Venture capitalists wrote bigger checks to fewer San Diego startups last year, leading to the...
San Diego spine tech company NuVasive lays off 157 workers
Local medical technology firm NuVasive laid off 157 workers in San Diego following the completion...
French pharma giant Sanofi buys San Diego biotech for $2.2B
French drugmaker Sanofi is buying San Diego-based Inhibrx, including a promising drug therapy, for up...
Gilead beat out Amazon for 27 acres in Oceanside. Now it is scrapping its development plans.
Gilead Sciences will not be moving forward with expansion plans to develop 27 acres of...
Illumina and the San Diego Zoo are sequencing koala genomes to investigate disease
Two world-class institutions that call San Diego home have ed forces on an investigation into...
Johnson & Johnson buys San Diego’s Ambrx Biopharma for $2B
Biopharma conglomerate Johnson & Johnson announced Monday it will buy San Diego-based Ambrx Biopharma for...
Illumina shells out $54 million to wiggle out of San Diego office deal
Illumina cut ties with its i3 campus in UTC last year to help trim $100...
San Diego biotech that makes non-hormonal birth control acquired for $100M
After a year of financial challenges and struggling to stay alive, San Diego women's health...
Investor Carl Icahn waging another proxy battle over Illumina’s failed acquisition of Grail
Less than 24 hours after biotech giant Illumina said it would divest early cancer detection...
Illumina will divest Grail after losing battle with FTC. How did the San Diego biotech’s $7B deal unravel?
San Diego biotech giant Illumina said Sunday that it is divesting Grail, the early cancer-detection...
San Diego sleep apnea device maker ResMed cuts workforce, restructures executive team
Local medical device maker ResMed is adjusting its executive leadership assignments and cutting back its...
Illumina says there is outside interest in buying Grail
San Diego’s DNA sequencing giant, Illumina told investors this week that it has received outside...
‘This is a game changer’: Eli Lilly is building coworking labs dedicated to San Diego biotech startups
San Diego’s world-renowned biotech cluster just gained a big investment from pharmaceutical giant Eli Lilly...
Startup partnership gives Sharp HealthCare a first look at next-generation medical technology
Sharp HealthCare is partnering with local incubator EvoNexus to help evaluate cutting-edge medical technology coming...
Unsealed lawsuit by investor Carl Icahn accuses board, ex-CEO of causing ‘Illumina to break the law’
Activist investor Carl Icahn is suing Illumina's ex-CEO and of its board over the...
Forget Silicon Valley – these Japanese life science firms came to San Diego to study startups
For 19 years, Takehito Matsuba worked for two big corporations in Tokyo — Mitsubishi and...
Bristol Myers Squibb buys San Diego cancer therapy company for $4.8B
Mirati Therapeutics, a San Diego biotechnology company developing commercial drugs for cancer treatment, was just...
San Diego’s Crinetics releases solid results for drug that treats deadly rare disease
Acromegaly is a rare disorder caused by a tumor on a person's pituitary gland that...
San Diego has a new CEO in town. Here’s what financial analysts are saying about Illumina’s next leader
Illumina, San Diego’s DNA-sequencing giant, has a new boss.Illumina’s board tapped Jacob Thaysen, a seasoned...
A broad genetic test saved one newborn’s life. Research suggests it could help millions of others
CINCINNATI — Brynn Schulte nearly died twice when she was a baby, at one point needing emergency...
Illumina lays off 151 San Diego workers
Illumina, a leading biotechnology company in DNA-sequencing, laid off 151 workers in San Diego as...
San Diego’s Illumina discloses new SEC investigation into its $7.1B acquisition of Grail
The U.S. Securities and Exchange Commission is investigating the $7.1 billion acquisition of Grail, a...
Thermo Fisher cuts 106 workers in fifth round of San Diego layoffs this year
Thermo Fisher Scientific is laying off 106 San Diego employees in the fifth round of...
12-year-old amputee surfs again with ‘water leg’ from this San Diego company
In June, Jonah Villamil hopped on a surfboard with two legs for the first time...
San Diego biotech Heron Therapeutics cuts 25% of workers, second corporate restructuring in a year
Heron Therapeutics, a San Diego biotechnology company that makes cancer and pain-management therapies, is cutting...
San Diego’s Travere Therapeutics to sell a piece of its liver disorder drug portfolio for $445M
San Diego’s Travere Therapeutics has inked a $445 million deal to sell part of its...
San Diego’s Illumina hit with hefty $476 million fine by European regulators over Grail merger
Illumina said it would appeal a $476 million fine levied Wednesday by the European Union...